3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine
C18H33N7O — CID 91792047
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine
3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine (PubChem CID 91792047) has the molecular formula C18H33N7O and a molecular weight of 363.51 g/mol. Its IUPAC name is 3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine.
Molecular Properties
| Compound Name | 3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine |
|---|---|
| PubChem CID | 91792047 |
| Molecular Formula | C18H33N7O |
| Molecular Weight | 363.51 g/mol |
| Exact Mass | 363.27 |
| IUPAC Name | 3-[4-methyl-5-[[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methyl]-1,2,4-triazol-3-yl]cyclobutan-1-amine |
| SMILES | Cn1c(CN2CCN(CCN3CCOCC3)CC2)nnc1C1CC(N)C1 |
| InChI | InChI=1S/C18H33N7O/c1-22-17(20-21-18(22)15-12-16(19)13-15)14-25-6-4-23(5-7-25)2-3-24-8-10-26-11-9-24/h15-16H,2-14,19H2,1H3 |
| InChIKey | ZPUKMGYVEHOTIH-UHFFFAOYSA-N |
| XLogP | -0.53 |
| TPSA | 75.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 363.51 |
| LogP ≤ 5 | -0.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91792047 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.